Guidelines for clinical practice of ALK fusion detection in non-small-cell lung cancer: a proposal from the Chinese RATICAL study group

Guidelines for clinical practice of ALK fusion detection in non-small-cell lung cancer: a proposal from the Chinese RATICAL study group

The presence of anaplastic lymphoma kinase (ALK) rearrangement defines a molecular subtype of non-small cell lung cancer (NSCLC). ALK inhibitors (ALKIs) confer significant clinical benefits in patients with ALK-positive advanced NSCLC; therefore, it is of great clinical significance to select accura...

Full description

Bibliographic Details
Main Authors: Wenbin Li, Jing Zhang, Zhijie Wang, Lin Li, Jie Ma, Xiaoyang Zhou, Jie Wang, Zhiyong Liang, Jianming Ying
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Journal of the National Cancer Center
Subjects:
ALK
Non-small cell lung cancer
Detection method
Online Access:http://www.sciencedirect.com/science/article/pii/S266700542100034X

Internet

http://www.sciencedirect.com/science/article/pii/S266700542100034X

Similar Items